Aifred is a clinical decision support system (CDSS) that uses artificial intelligence to assist
physicians in selecting treatments for major depressive disorder (MDD) by providing …

Background Approximately two-thirds of patients with major depressive disorder do not
achieve remission during their first treatment. There has been increasing interest in the use of …

BackgroundRecently, artificial intelligence-powered devices have been put forward as
potentially powerful tools for the improvement of mental healthcare. An important question is how …

Aifred Health, one of the top two teams in the first round of the IBM Watson AI XPRIZE
competition, is using deep learning to solve the problem of treatment selection and prognosis …

Clinical decision support systems (CDSS) augmented with artificial intelligence (AI) models
are emerging as potentially valuable tools in healthcare. Despite their promise, the …

Background: Deep learning has utility in predicting differential antidepressant treatment
response among patients with major depressive disorder, yet there remains a paucity of …

Background Depression affects one in nine people, but treatment response rates remain low.
There is significant potential in the use of computational modelling techniques to predict …

In conventional non-quantitative magnetic resonance imaging, image contrast is consistent
within images, but absolute intensity can vary arbitrarily between scans. For quantitative …

Machine-assisted treatment selection commonly follows one of two paradigms: a fully
personalized paradigm which ignores any possible clustering of patients; or a sub-grouping …

Mental health conditions cause a great deal of distress or impairment; depression alone will
affect 11% of the world’s population. The application of Artificial Intelligence (AI) and big-…